<DOC>
	<DOCNO>NCT02479971</DOCNO>
	<brief_summary>A prospective , randomize study perform patient undergo laparoscopic sleeve gastrectomy ( LSG ) bariatric procedure . The patient randomize 2 group : patient undergo intra-abdominal lavage normal saline ( Group 1 ) undergo intra-abdominal lavage gentamicin-clindamycin solution ( Group 2 ) . Postoperative pain C reactive protein investigate 24 hour surgery .</brief_summary>
	<brief_title>Effect Peritoneal Lavage With Clindamycin-gentamicin Laparoscopic Sleeve Gastrectomy</brief_title>
	<detailed_description>A prospective , randomize study performedin patient undergo laparoscopic sleeve gastrectomy ( LSG ) bariatric procedure . The patient randomize 2 group : patient undergo intra-abdominal lavage normal saline ( Group 1 ) undergo intra-abdominal lavage gentamicin-clindamycin solution ( Group 2 ) . Postoperative pain C reactive protein investigate 24 hour surgery .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<criteria>Body mass index ( BMI ) &gt; 40 Kg/m2 BMI &gt; 35 Kg/m2 presence comorbidities associate obesity Patients undergoing laparoscopic sleeve gastrectomy ( LSG ) bariatric procedure . Gastroesophageal reflux Preoperative diagnosis chronic renal failure Uncontrolled psychiatric disorder Active infection Malignancies Any concomitant pathology consider contraindication bariatric surgery .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>